Evaluation and management of the pelvic mass: a review of 540 cases

• Published in: Obstetrics and gynecology (New York. 1953) Vol. 71; no. 3 Pt 1; p. 319
• Main Authors: Killackey, M A, Neuwirth, R S
• Format: Journal Article
• Language: English
• Published: United States 01-03-1988
• Subjects: Adolescent; Adult; Age Factors; Aged; Child; Endometriosis - pathology; Endometriosis - surgery; Female; Humans; Laparotomy; Leiomyoma - diagnosis; Leiomyoma - pathology; Leiomyoma - surgery; Middle Aged; Ovarian Cysts - pathology; Ovarian Cysts - surgery; Pelvic Inflammatory Disease - pathology; Pelvic Inflammatory Disease - surgery; Pelvic Neoplasms - diagnosis; Pelvic Neoplasms - pathology; Pelvic Neoplasms - surgery; Uterine Neoplasms - pathology; Uterine Neoplasms - surgery
• ISSN: 0029-7844

The management of 540 patients with the diagnoses of "pelvic mass/uterine leiomyomata" was reviewed with respect to preoperative evaluation, surgical procedures, and final pathologic diagnosis. Approximately 6170 patients were admitted to the Gynecology Service at St. Luke's-Roosevelt Hospital Center from July 1984 to June 1985. During this period, 36 of 432 diagnostic laparoscopies (8.3%) and 503 of 1666 laparotomies (30.2%) were performed to evaluate or treat these women. The final diagnoses in the 249 patients admitted with the impression of leiomyomata were: leiomyomata, 235 (94.4%); benign adnexal masses, seven (2.8%); cancers, four (1.6%); and miscellaneous, three (1.2%). Of the 291 patients evaluated for pelvic mass, the findings were: benign ovarian or tubal cysts, 98 (33.7%); leiomyomata, 42 (14.4%); cancers, 40 (13.7%); benign cystic teratomas, 38 (13.1%); endometriosis, 28 (9.6%); miscellaneous, 23 (7.9%); and pelvic inflammatory disease, 22 (7.6%). Correlation between the patient's age, preoperative impression, and final diagnosis is presented with particular attention to the 44 patients (8.1%) in whom malignancy was found. All the possibilities that such masses may represent must be considered preoperatively, and the patient be informed of her risk of malignancy.